样式: 排序: IF: - GO 导出 标记为已读
-
Correction to “Predictive factors for the success of trial without catheter for men with urinary retention” Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2024-02-14
Takanashi M, Ito H, Fukazawa T, et al. Predictive factors for the success of trial without catheter for men with urinary retention. Lower Urinary Tract Symptoms. 2023;15(5):173-179. doi:10.1111/luts.12492 In Results section of abstract, “(P = 0.042, odds ratio [OR] 1.701) and PS <2 in naïve patients (P = 0.001, OR 2.710)” was incorrect. This should have read “(P = 0.021, odds ratio [OR] 1.037) and
-
Comparison between combination of tamsulosin and Pentoxifylline versus tamsulosin alone in the treatment of lower urinary tract symptoms due to benign prostate hyperplasia: A preliminary study Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2024-01-03 Mehdi Shirazi, Alireza Dehghanmanshadi, Soroush Sadr, Zahra Jahanabadi
In older adults, bladder outlet obstruction (BOO) is prevalent, primarily due to benign prostatic hyperplasia (BPH). These patients' lower urinary tract symptoms can be treated surgically and with medical therapy. Compared to standard treatment with tamsulosin, Pentoxifylline, a phosphodiesterase inhibitor, could benefit patients with BOO due to its properties on microcirculatory blood flow and oxygenation
-
Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-11-21 Wan-Ru Yu, Hann-Chorng Kuo
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease characterized by bladder pain, frequency, and nocturia. The most common pathologies include chronic inflammation and bladder urothelium dysfunction. According to the bladder condition with or without Hunner's lesions, IC/BPS can be divided into “IC” in patients with Hunner's lesion (HIC) and “BPS” in those without Hunner's lesion
-
Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-11-20 Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii
To evaluate longitudinal changes in lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation in patients undergoing radiation therapy (RT) in comparison to those in non-irradiated patients.
-
Association between voiding lower urinary tract symptoms and findings on dynamic magnetic resonance imaging with regard to pelvic organs and their supportive structures Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-10-22 Shoutarou Watanabe, Kurenai Kinno, Yasuharu Takeuchi, Yoshitomo Sawada, Noritoshi Sekido
Pelvic organ prolapse (POP) causes voiding lower urinary tract symptoms (vLUTS). In the present study, we investigated the association between vLUTS and pelvic organ mobility (POM), including relevant supportive structures, on dynamic magnetic resonance imaging (dMRI).
-
Optimal endoscopic treatment and partial cystectomy with or without bladder augmentation for Hunner-type interstitial cystitis Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-09-26 Jiwoong Yu, Chung Un Lee, Kyu-Sung Lee, Kwang Jin Ko
Interstitial cystitis/bladder pain syndrome (IC/BPS) presents a significant challenge for urologists in terms of management, owing to its chronic nature and adverse impact on patient quality of life. Given the potential distinction between two disease entities within IC/BPS, namely Hunner-type IC and BPS without Hunner lesion, there is a need for an optimal therapeutic approach that focuses on the
-
Effects of a new selective β3-adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-09-18 Mio Togo, Takeya Kitta, Hiroki Chiba, Madoka Higuchi, Naohisa Kusakabe, Mifuka Ouchi, Yui Abe-Takahashi, Hidehiro Kakizaki, Nobuo Shinohara
Parkinson's disease caused by the loss of dopaminergic neurons induces not only motor dysfunction but also lower urinary tract dysfunction. Patients with Parkinson's disease have recently been reported to experience both urge urinary incontinence (overactive bladder) and stress urinary incontinence, the latter of which occurs when the pressure of the bladder exceeds that of the urethra. Vibegron is
-
Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-09-13 Hann-Chorng Kuo
The urothelium acts as a barrier for the urinary bladder that prevents the influx of urinary toxic substances, electrolytes, urea nitrogen, and pathogens into the circulation. Acute or chronic inflammation of the urinary bladder may impair the regenerative function of urothelial cells and thus urothelial cell differentiation. In an inflamed bladder wall, mature apical cells are defective, resulting
-
Number of patients with interstitial cystitis/bladder pain syndrome seen before versus during the COVID-19 pandemic at an academic, urban, multisite urogynecology practice Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-09-12 Tahireh Markert, Alexa Courtepatte, Subrina Farah, Jeannine M. Miranne
Little is known about the impact of the COVID-19 pandemic on interstitial cystitis/bladder pain syndrome (IC/BPS). We aim to compare the number of newly diagnosed IC/BPS cases and number of patients with flares prior to and during the pandemic.
-
Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-09-08 Kazumasa Torimoto, Tomohiro Ueda, Daisuke Gotoh, Kuniyuki Kano, Makito Miyake, Yasushi Nakai, Shunta Hori, Yosuke Morizawa, Kenta Onishi, Takuto Shimizu, Mitsuru Tomizawa, Junken Aoki, Kiyohide Fujimoto
Diagnosing interstitial cystitis/bladder pain syndrome presents a major challenge because it relies on subjective symptoms and empirical cystoscopic findings. A practical biomarker should discriminate diseases that cause increased urinary frequency, particularly overactive bladder. Therefore, we aimed to identify blood biomarkers that can discriminate between interstitial cystitis/bladder pain syndrome
-
The expression and distribution of TACAN in human and rat bladders Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-08-31 Qudong Lu, Qian Liu, Shiwei Chen, Jiaolian Wang, Yongjie Chen, Bishao Sun, Zhenxing Yang, Huan Feng, Shanhong Yi, Wei Chen, Jingzhen Zhu
A lot of ion channels participate in the regulation of bladder function. TACAN, a new mechanosensitive ion channel, was first discovered in 2020. TACAN has been found to be expressed in many tissues, such as the dorsal root ganglia (DRG) and adipose tissue. However, it is unclear whether or not TACAN is expressed in the bladder. In this work, we decided to study the expression and distribution of TACAN
-
Uroflowmetry parameters in healthy children between 5 and 15 years old Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-08-23 Yeşim Demirkıran Öztürk, Ahmet Taner Elmas, Yılmaz Tabel
Uroflowmetry (UFM) is the first-line noninvasive screening test employed in the diagnosis of lower urinary tract dysfunction (LUTD). The purpose of this study was to determine normal UFM values in healthy Turkish children among our local population.
-
Efficacy of cognitive behavioral therapy using self-check sheet for patients with nocturia in real-world clinical practice Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-08-23 Yuki Kyoda, Koji Ichihara, Ippei Muranaka, Yasuyuki Sakai, Makoto Nakamura, Nobuo Shinkai, Nodoka Kozen, Wakako Yorozuya, Daichi Morooka, Kazutaka Maruo, Kimihito Tachikawa, Kosuke Shibamori, Seisuke Nofuji, Keiko Fujino, Shuichi Kato, Takashi Yoshida, Tetsuya Shindo, Takeshi Maehana, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori
We previously demonstrated the efficacy of cognitive behavioral therapy (CBT) using a self-check sheet for patients with nocturia in a randomized controlled study. Additionally, we investigated the efficacy of the intervention in real-world clinical practice.
-
Correction to “Hip dysfunction-related urinary incontinence and total hip arthroplasty with the direct lateral approach” Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-07-19
Abed MH, Vasaghi-Gharamaleki B, Ghazavi MT, Nikjooy A. Hip dysfunction-related urinary incontinence and total hip arthroplasty with the direct lateral approach. Lower Urinary Tract Symptoms. 2023;15(1):11–15. doi:10.1111/luts.12466 Some of the values in Table 1 were incorrect. Please see revised table below: TABLE 1. Results from ICIQ questionnaire in patients with urinary incontinence and secondary
-
Utilization and safety of telemedicine for pediatric lower urinary tract symptoms before and during the COVID-19 pandemic Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-07-13 Abby L. Chen, Stav Spinzi, Gunjan Agrawal, Kathleen M. Kan
Telemedicine for pediatric lower urinary tract symptoms (pLUTS) is a relatively new mode of delivering bladder health education with scant evidence supporting current practice. We aim to examine the safety of pLUTS-related telemedicine visits surrounding the COVID-19 pandemic.
-
Incidence and predictors of urinary incontinence rates post-holmium laser enucleation of prostate Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-06-27 Mohamed Elsaqa, Yu Zhang, Harry Papaconstantinou, Marawan M. El Tayeb
One of the main adverse outcomes following Holmium laser enucleation of the prostate (HoLEP) is the development of transient de novo urinary incontinence (UI). We aimed to evaluate the correlation of multiple risk factors to UI rates post-HoLEP.
-
Urinary incontinence in the postpartum 1-year period: Its prevalence and effect on psychosocial status of women Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-06-26 Gulennur Suar, Feride Cevik, Nurgul Simal Yavuz, Nebahat Ozerdogan
In this study, it was aimed to determine the prevalence and effect of urinary incontinence in the postpartum 1 year period on psychosocial status of women.
-
Memorial address for Emeritus Professor Osamu Yamaguchi-A man of learning. Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-06-15 Osamu Nishizawa
-
Correlation of resistive index of prostatic capsular artery to clinical symptoms in men with chronic prostatitis/chronic pelvic pain syndrome Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-06-14 Yasin Yitgin, Ayhan Karakose
To evaluate the relation between resistive index (RI) of prostatic capsular arteries by transrectal Doppler ultrasonography in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and its correlation with lower urinary tract symptoms, erectile dysfunction and premature ejaculation parameters of CP/CPPS.
-
Hygiene management of intermittent self-catheterization using reusable silicone catheters in people with spinal cord lesions: A cross-sectional Internet survey in Japan Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-06-10 Ryosuke Takahashi, Noritoshi Sekido, Mihoko Matsuoka, Atsushi Sengoku, Masashi Nomi, Fujio Matsuyama, Tatsunori Murata, Takeya Kitta, Takahiko Mitsui
To investigate hygiene management and catheter maintenance of reusable silicone catheters for intermittent self-catheterization (ISC) in Japan and examine their relationship with symptomatic urinary tract infection (sUTI).
-
Predictive factors for the success of trial without catheter for men with urinary retention Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-06-05 Masato Takanashi, Hiroki Ito, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Risa Shinoki, Takashi Kawahara, Kazuki Kobayashi
To investigate the trial of spontaneous urination without catheter (TWOC) outcomes for men with acute urinary retention, determine successful TWOC predictors, and evaluate the impact of add-on medication therapy on TWOC.
-
Risk factors for a failed trial without catheter following convective water vapor thermal therapy (CWVTT-Rezum) Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-05-26 Michael D. Felice, Kaylin Kim, Sarang Janakiraman, Gaurav Pahouja, William Adams, Erin Fruth, Ahmer Farooq, Kevin T. McVary
Convective water vapor thermal therapy (CWVTT-Rezum) is a minimally invasive surgical therapy that is being increasingly utilized for bladder outlet obstruction. Most patients leave the site of care with a Foley catheter in place for a mean reported duration of 3–4 days. A minority of men will fail their trial without catheter (TWOC). We aim to identify the frequency of TWOC failure following CWVTT
-
Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms—A randomized controlled trial Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-05-16 Hao Xiang Chen, Shih-Hsin Chang, Der-Yuan Chen, Joung-Liang Lan, Kai-Jieh Yeo, Po-Hao Huang, Chung-Ming Huang, Chi-Ping Huang, Eric Chieh-Lung Chou, Po-Chang Wu
This study investigates the efficacy and adverse events of beta-3 agonists and antimuscarinic agents for managing overactive bladder syndrome in Sjogren syndrome.
-
Efficacy and safety of the Rezum system for the treatment of catheter-dependent urinary retention: Three-year real-world outcomes in a multimorbid, multiethnic population Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-05-15 Mustufa Babar, Zaki Masoud, Kevin Labagnara, Justin Loloi, Rahman Sayed, Sandeep Singh, Kevin Tang, Umar Syed, Michael Ciatto
To evaluate the long-term real-world efficacy and safety of Rezum for the treatment of catheter-dependent urinary retention in a multimorbid, multiethnic population.
-
Mirabegron versus vibegron in previously untreated female patients with overactive bladder: A randomized, single-clinic, open-label trial Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-05-04 Hirotaka Sato, Shota Otsuka, Sachiyuki Tsukada
This study aimed to assess the efficacy and safety of mirabegron compared with vibegron (both 50 mg once daily) in Japanese female patients with symptoms of overactive bladder (OAB).
-
The efficacy of antibiotic and alpha-blocker combination therapy versus antibiotic monotherapy in chronic prostatitis/chronic pelvic pain syndrome: A systematic review Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-04-02 Fina Widia, Widi Atmoko, Natanael Parningotan Agung, Harrina Erlianti Rahardjo, Nur Rasyid, Ponco Birowo, Akmal Taher
This study attempted to explore the efficacy of a combination of alpha-blockers and antibiotics compared with antibiotic monotherapy in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
-
Lower urinary tract symptoms are elevated with depression in Japanese women Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-03-30 Sahoko Ninomiya, Takashi Kawahara, Sohgo Tsutsumi, Hiroki Ito, Kazuhide Makiyama, Hiroji Uemura
Depression might worsen lower urinary tract symptoms (LUTS), but the correlation is still disputed. This study examined the influence of depression on LUTS in Japanese women.
-
Anatomic outcomes of sacrohysteropexy without posterior mesh placement in patients with asymptomatic grade 1 and 2 rectoceles: Is a rectouterine mesh really necessary? Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-03-30 Adem Sancı, Khaled Obaid, Murat Topcuoglu, Mehmet İlker Gokce, Evren Süer, Ömer Gülpinar
To present the anatomic outcomes of sacrohysteropexy surgery without posterior mesh placement in patients with asymptomatic grade 1 and 2 rectoceles.
-
TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-03-04 Federica Sala, Melania Loggia, Giorgia Cardella, Claudia Morgani, Giovanni Grossi, Marzio Angelo Zullo, Herbert Carmelo Carlo Valensise, Pier Luigi Palazzetti, Michele Carlo Schiavi
The aim of this study was to compare the efficacy of the transobturator tape (TOT) procedure combined with solifenacin (TOT-S) or prasterone (TOT-P) in postmenopausal women affected by mixed urinary incontinence (MUI) with a predominant stress urinary incontinence component.
-
Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta-analysis Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-03-02 Wenjuan He, Yuqian Zhang, Guangliang Huang, Yunfei Tian, Qian Sun, Xiuju Liu
The aim of this study was to indirectly compare the efficacy and safety of mirabegron and vibegron in patients with overactive bladder.
-
Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-02-08 Hirofumi Kurose, Keisuke Komiya, Naoyuki Ogasawara, Kosuke Ueda, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Mitsunori Matsuo, Shigetaka Suekane, Tsukasa Igawa
There is no consistent opinion on the optimal initial dose of desmopressin for patients with nocturnal polyuria. Over a period of 12 weeks, we investigated the safety and efficacy of an initial dose of 50 μg of desmopressin for elderly men.
-
Does histological prostatic inflammation during transurethral resection of the prostate for bladder outlet obstruction affect post-operative urinary outcomes? Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2023-01-23 Bharti Arora, Munad Khan, Simon Pridgeon
Benign prostate hyperplasia (BPH) is a common cause for bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS) in men. The pathophysiology of BPH is multifactorial and inflammation has been linked with progression of BPH and LUTS. The association between histological prostatitis found at transurethral resection of the prostate (TURP) and adverse post-operative urinary outcomes is
-
Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M3-muscarinic antagonist and a β3-adrenergic agonist Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-12-21 Hiroaki Hara, Tetsuya Imamura, Ataru Suzuki, Manabu Ueno, Tomonori Minagawa, Teruyuki Ogawa, Osamu Ishizuka
Goto-Kakizaki (GK) rats with type 2 diabetes mellitus respond to low temperature (LT) environments with bladder overactivity, including increased voiding frequency and decreased voiding interval and micturition volume. We determined if bladder overactivity could be inhibited by treatment with the combination of a M3-muscarinic receptor antagonist and a β3-adrenergic receptor agonist.
-
Factors predicting treatment success in mixed urinary incontinence treated with midurethral sling Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-12-19 Cuneyd Ozkurkcugil, Ibrahim Erkut Avci
We aimed to investigate success rates and predictive factors for midurethral slings (MUS) in women with mixed urinary incontinence (MUI).
-
Age-specific effect of transurethral holmium laser enucleation of the prostate on overactive bladder in men with benign prostatic hyperplasia: An investigation using an overactive bladder symptom score Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-12-11 Yasuharu Takeuchi, Yoshitomo Sawada, Shoutarou Watanabe, Yasuo Ni-itsu, Noritoshi Sekido
To investigate the age-specific effect of transurethral holmium laser enucleation of the prostate (HoLEP) on overactive bladder (OAB).
-
Effect of intravesical tarantula cubensis extract (Theranekron) on inflammation in an interstitial cystitis rat model Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-12-07 Akdağ Abdullah, Yenisey Çiğdem, Epikmen E. Tuğrul, Ateş Erhan
To reveal the histopathological and immunological outcomes of intravesical treatment with tarantula cubensis extract (TCE) in a rat model of interstitial cystitis.
-
Effectiveness of game-based core exercise in children with non-neuropathic bladder dysfunction and comparison to biofeedback therapy Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-11-11 Melek Havva Kilcik, Filiz Ozdemir, Ahmet Taner Elmas
This study was planned to evaluate the effectiveness of game-based core exercises in children diagnosed with non-neuropathic bladder dysfunction and compare this effectiveness to that of the biofeedback treatment method.
-
Quality and content analysis of female urethroplasty videos on YouTube Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-10-31 Yusuf Sahin, Filip Paslanmaz, Ismail Ulus, Mehmet Yilmaz, Muhammet Murat Dincer, Ahmet Yaser Muslumanoglu
In this study, we aimed to analyze scientific quality and content of female urethroplasty videos on YouTube.
-
Hip dysfunction-related urinary incontinence and total hip arthroplasty with the direct lateral approach Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-10-27 Maryam Hakimi Abed, Behnoosh Vasaghi-Gharamaleki, Mohammad Taghi Ghazavi, Afsaneh Nikjooy
There is a functional relationship between the hip joint and the pelvic floor muscles. In patients with secondary osteoarthritis of the hip, urinary incontinence is also seen. Research has shown that total hip arthroplasty (THA) surgery improves the symptoms of urinary incontinence. This prospective cross-sectional study without a control group was performed on THA candidates with urinary incontinence
-
Collateral damage of wandering ProTacks Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-10-18 Deepak Batura, Iqbal Sahibzada, Wade Gayed
A 75-year-old man presented with mixed obstructive and storage lower urinary tract symptoms (LUTS). He had undergone transurethral resection of the prostate (TURP) 5 years and laparoscopic inguinal hernia repair 20 years ago. He had a stone adherent to the bladder wall and an occlusive prostate.
-
Predictive factors for the success of trial catheter removal for women with urinary retention Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-10-17 Masato Takanashi, Hiroki Ito, Takeshi Fukazawa, Risa Shinoki, Tadashi Tabei, Takashi Kawahara, Kazuki Kobayashi
To investigate the outcome, determine the predictors for the success of, and evaluate the efficacy of pharmacokinetic therapy on trial catheter removal for women with urinary retention.
-
Trends in minimally invasive surgical therapies for overactive bladder management in Australia Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-09-13 Paul Brian Ng Hung Shin, Handoo Rhee, Eric Chung
To evaluate the national trends in minimally invasive surgical therapies (MIST) for overactive bladder (OAB) in Australia over the past decade.
-
Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-09-04 Saori Yonekubo-Awaka, Motohiro Tezuka, Satoshi Tatemichi, Hiroo Takeda
Pharmacological treatment options for underactive bladder (UAB) syndrome are limited. Urapidil is the only alpha1-adrenoceptor (AR) antagonist that can be used for urinary disorders in women in some countries. However, no studies have directly verified the effects of alpha1-AR antagonists on the female urethra and UAB-like dysfunctions. We investigated the effects of silodosin (alpha1A-AR antagonist)
-
Corrigendum Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-09-01
In Tamalunas et al.,1 the following error was published on page 22. In Table 4, the authors would like to correct the percentage values in columns two, three and four. TABLE 4. Perioperative adverse events (AEs) in groups 1-3 according to the Clavien-Dindo classification. The following AEs were identified and consecutive management is given in the table AEs Group 1 (≤60 cc) n = 157 Group 2 (>60 < 120 cc)
-
Is artificial urinary sphincter surgery safe and effective in elderly males aged 70 years and above? Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-08-24 Eric Chung, Juan Wang, Ross Cartmill
To evaluate the clinical outcomes and patient satisfaction rate between men aged under and over 70 years who underwent artificial urinary sphincter (AUS) surgery.
-
Reliability and validity of the Turkish language version of the Core Lower Urinary Tract Symptom Score Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-08-17 Mehmet E. Erbay, Sena T. Tarhan
The purpose of this study was to develop the Turkish version of the Core Lower Urinary Tract Symptom Score (CLSS) and determine its psychometric properties in Turkish subjects.
-
Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real-world multicenter clinical study Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-08-05 Yuki Kyoda, Makoto Kimura, Takashi Shimizu, Noriomi Miyao, Takuto Ogasawara, Toshiaki Shimizu, Akihiko Iwasawa, Wakako Yorozuya, Jiro Hashimoto, Koji Ichihara, Fumiyasu Takei, Kosuke Uchida, Nodoka Kouzen, Noriyoshi Suzuki, Kimihito Tachikawa, Akihiko Shibuya, Ippei Muranaka, Manabu Okada, Manabu Igarashi, Kosuke Shibamori, Seisuke Nofuji, Keiko Fujino, Tomohiro Toyota, Yu Ito, Nobuo Shinkai, Kohei
To clarify Japanese real-world clinical data on the use of desmopressin 25 and 50 μg orally disintegrating tablets (ODT) for male patients with nocturia and evaluate the predictive factors to improve nighttime frequency.
-
Efficacy of tadalafil on symptom-specific bother in men with lower urinary tract symptoms Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-07-13 Naoki Hirahara, Shunji Harikai, Atsuko Fujihara, Yasuhiro Yamada, So Ushijima, Osamu Ukimura
This multicenter and prospective study was performed to evaluate the efficacy of tadalafil on patient-reported bother for each symptom in men with lower urinary tract symptoms (LUTS).
-
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-07-09 Raziye Ergun, Naime Ipek Ozturk, Cagri Akin Sekerci
Biofeedback is an effective treatment in children with standard urotherapy-resistant dysfunctional voiding (DV). However, the duration of the session intervals is not standardized. We aimed to compare the effectiveness of daily and weekly sessions of biofeedback treatments.
-
Prevalence of symptoms of pelvic floor dysfunction and related factors among Japanese female healthcare workers Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-06-27 Moe Sawai, Chikako Yuno, Miho Shogenji, Harumi Nakada, Yoko Takeishi, Maiko Kawajiri, Yasuka Nakamura, Toyoko Yoshizawa, Mikako Yoshida
Women working in the medical field may be at risk for pelvic floor dysfunction due to high physical activity levels leading to increased abdominal pressure; however, the actual situation remains unknown. This study aimed to clarify the prevalence of symptoms of pelvic floor dysfunction and its associated factors among Japanese women working in the medical field.
-
Association of lower urinary tract symptoms and diuretic adherence Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-06-23 Matthew L. Miller, Brent N. Reed, Rena D. Malik
To assess whether more severe urinary symptoms and poorer quality of life among patients on diuretic therapy are associated with decreased adherence to the diuretic regimen.
-
A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-06-19 Tatsunori Okada, Mikifumi Koura, Ryota Sumikawa, Hiroyuki Masaoka, Yoohyun Song, Takashi Dejima, Narihito Seki
This study aimed to compare the safety and efficacy of three different laser prostate vaporization surgeries, which were photoselective vaporization of the prostate (PVP), diode laser vaporization (DVP), and thulium laser vaporization (ThuVAP), for the treatment of benign prostatic hyperplasia (BPH) in a randomized clinical trial.
-
Use of the penile cuff test to diagnose bladder outlet obstruction: A systematic review and meta-analysis Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-06-18 Lakshay Khosla, Alia Codelia-Anjum, Christina Sze, Susana Martinez Diaz, Kevin C. Zorn, Naeem Bhojani, Dean Elterman, Bilal Chughtai
Among noninvasive modalities for assessing bladder outlet obstruction (BOO), the penile cuff test (PCT) is the most used in clinical practice. The purpose of this review was to evaluate the performance of PCT in diagnosing and managing BOO.
-
Effects of transobturator tape procedure on female sexual function at 2-year follow-up: A prospective cohort study with matched control group Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-05-23 Nergis Kender Erturk, Fatma Nurgul Tasgoz, Muzaffer Temur
We aimed to compare the effect of elapsed time on sexual function in women who underwent a transobturator tape (TOT) procedure for stress urinary incontinence (SUI) with continent controls.
-
Neurogenic lower urinary tract dysfunction in association with severity of degenerative spinal diseases: Short-term outcomes of decompression surgery Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-05-10 Shingo Kimura, Shunichi Takyu, Naoki Kawamorita, Takashige Namima, Naoki Morozumi, Akihiro Ito
Cervical myelopathy (CM) and lumbar canal stenosis (LCS) are common degenerative spinal diseases among the elderly, and the major associated complaints include lower urinary tract symptoms (LUTS). The aim of this study was to investigate subjective and objective urological parameters of patients undergoing decompression surgery for CM and LCS.
-
Do we have enough evidence to propose a urinary biomarker of bladder ischemia? A systematic review and meta-analysis Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-04-19 Efstathios Papaefstathiou, Maria Papaioannou, Eirini Papaefstathiou, Aikaterini Apostolopoulou, Apostolos Apostolidis
Urinary bladder ischemia has been implicated in the pathogenesis of lower urinary tract symptoms (LUTS). However, research regarding urinary molecular markers for diagnosis and prognosis of pelvic ischemia is still premature, hindering further implementation in clinical practice. The aim of this study is to systematically appraise biomarkers associated with bladder ischemia detected in urine.
-
Comparing surgical interventions for interstitial cystitis: A systematic review Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-04-08 Diego Agustín Abelleyra Lastoria, Nicholas Raison, Abdullatif Aydin, Shamim Khan, Prokar Dasgupta, Kamran Ahmed
The purpose of this review was to summarize and compare the efficacy among surgical interventions in terms of symptomatic relief in patients with interstitial cystitis/bladder pain syndrome (IC/BPS). The review protocol was published on PROSPERO. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 checklist was followed. Following database search, a narrative synthesis
-
Through the zipper or pants down: Does it change uroflowmetry parameters in healthy males? Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-04-05 Muhammet İrfan Dönmez, Mehmet Serkan Özkent, Mustafa Bilal Hamarat, Mehmet Kocalar
To evaluate if voiding through the zipper or voiding pants down would make any difference with regard to uroflowmetry parameters and postvoiding residual urine (PVR) volumes in healthy males with no lower urinary tract symptoms (LUTS).
-
Rare cases of vesicouterine fistula Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-03-27 Maulidina Medika Rahmita, Arry Rodjani, Irfan Wahyudi, Fina Widia
Vesicouterine fistula (VUF) is the rarest form of genitourinary fistulas. As lower-segment cesarean section becomes a more common mode of delivery, they have become the leading cause of VUF formation. We present four VUF patients with varied symptoms such as menouria, amenorrhea, with or without urinary incontinence. We diagnosed all of our cases through cystoscopy in conjunction with methylene blue
-
Prevalence and factors associated with urinary incontinence in female crossfitters: A cross-sectional study Luts Lower Urin. Tract Symptoms (IF 1.3) Pub Date : 2022-03-22 Elizabete de Souza Pereira, Ana Paula de Lima Ferreira, Milene de Oliveira Almeida, Cinthia Silva Barbosa, Gleyce de Melo Falcão Monteiro, Leila Barbosa, Andrea Lemos
To determine the prevalence and factors associated with urinary incontinence (UI) in female crossfitters.